Literature DB >> 26902205

General Assessment of Humoral Activity in Healthy Humans.

Phillip Stafford1, Daniel Wrapp2, Stephen Albert Johnston1.   

Abstract

The humoral immune system is network of biological molecules designed to maintain a healthy homeostatic equilibrium. Because antibodies are an abundant and highly specific effector of immunological action, they are also an important reservoir of previous host exposures. Antibodies may play a major role in early detection of host challenge. Unfortunately, few practical methods exist for interpreting the information stored in antibody variable regions. Immunosignatures use a microarray of thousands of random sequence peptides to interrogate antibodies in a broad and unbiased fashion. The pattern of binding between antibody and peptide is reproducible. Once the system has been trained on a disease cohort, blinded samples can be reliably predicted. Although immunosignatures of both chronic and infectious disease have been extensively tested, less has been done to demonstrate how healthy immunosignatures change over time or between individuals. Here, we report the results of a study of immunosignatures of healthy persons over brief (12 h sampled once per hour), intermediate (32 days sampled once per day), and long (5 years sampled once every year) time spans. Using this information, we were also able to detect intentional and unintentional immunological perturbations in the form of a vaccine and an infection, respectively. Our findings suggest that, even with the variability inherent in healthy immunosignatures, a single person's immunosignature will remain constant over time. Over this healthy signature, vaccines and infections create subsignatures that are common across multiple people, even subsuming healthy fluctuations. These findings have implications for disease monitoring and early diagnosis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902205      PMCID: PMC4858943          DOI: 10.1074/mcp.M115.054601

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  25 in total

1.  A general method for characterization of humoral immunity induced by a vaccine or infection.

Authors:  Joseph Barten Legutki; D Mitchell Magee; Phillip Stafford; Stephen Albert Johnston
Journal:  Vaccine       Date:  2010-05-05       Impact factor: 3.641

2.  New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action.

Authors:  Abner Louis Notkins
Journal:  Sci Am       Date:  2007-03       Impact factor: 2.142

3.  Epitope identification from fixed-complexity random-sequence peptide microarrays.

Authors:  Josh Richer; Stephen Albert Johnston; Phillip Stafford
Journal:  Mol Cell Proteomics       Date:  2014-11-03       Impact factor: 5.911

Review 4.  Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Authors:  François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

5.  Immunosignature system for diagnosis of cancer.

Authors:  Phillip Stafford; Zbigniew Cichacz; Neal W Woodbury; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

6.  The impact of self-identified race on epidemiologic studies of gene expression.

Authors:  Sunita Sharma; Amy Murphy; Judie Howrylak; Blanca Himes; Michael H Cho; Jen-Hwa Chu; Gary M Hunninghake; Anne Fuhlbrigge; Barbara Klanderman; John Ziniti; Jody Senter-Sylvia; Andy Liu; Stanley J Szefler; Robert Strunk; Mario Castro; Nadia N Hansel; Gregory B Diette; Becky M Vonakis; N Franklin Adkinson; Vincent J Carey; Benjamin A Raby
Journal:  Genet Epidemiol       Date:  2011-02       Impact factor: 2.135

7.  Application of immunosignatures for diagnosis of valley fever.

Authors:  Krupa Arun Navalkar; Stephen Albert Johnston; Neal Woodbury; John N Galgiani; D Mitchell Magee; Zbigniew Chicacz; Phillip Stafford
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

8.  Immunosignaturing can detect products from molecular markers in brain cancer.

Authors:  Alexa K Hughes; Zbigniew Cichacz; Adrienne Scheck; Stephen W Coons; Stephen Albert Johnston; Phillip Stafford
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

9.  Physical characterization of the "immunosignaturing effect".

Authors:  Phillip Stafford; Rebecca Halperin; Joseph Bart Legutki; Dewey Mitchell Magee; John Galgiani; Stephen Albert Johnston
Journal:  Mol Cell Proteomics       Date:  2012-01-18       Impact factor: 5.911

10.  Diagnosis and early detection of CNS-SLE in MRL/lpr mice using peptide microarrays.

Authors:  Stephanie Williams; Phillip Stafford; Steven A Hoffman
Journal:  BMC Immunol       Date:  2014-06-07       Impact factor: 3.615

View more
  6 in total

1.  Antibody repertoire profiling with mimotope arrays.

Authors:  Shina Pashova; Christoph Schneider; Stephan von Gunten; Anastas Pashov
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

2.  Diagnostic Profiling of the Human Public IgM Repertoire With Scalable Mimotope Libraries.

Authors:  Anastas Pashov; Velizar Shivarov; Maya Hadzhieva; Victor Kostov; Dilyan Ferdinandov; Karen-Marie Heintz; Shina Pashova; Milena Todorova; Tchavdar Vassilev; Thomas Kieber-Emmons; Leonardo A Meza-Zepeda; Eivind Hovig
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

Review 3.  Scoping review of the applications of peptide microarrays on the fight against human infections.

Authors:  Arthur Vengesai; Maritha Kasambala; Hamlet Mutandadzi; Tariro L Mduluza-Jokonya; Takafira Mduluza; Thajasvarie Naicker
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

4.  Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Oliver P Günther; Jennifer L Gardy; Phillip Stafford; Øystein Fluge; Olav Mella; Patrick Tang; Ruth R Miller; Shoshana M Parker; Stephen A Johnston; David M Patrick
Journal:  Mol Neurobiol       Date:  2018-10-08       Impact factor: 5.590

5.  A general approach for predicting protein epitopes targeted by antibody repertoires using whole proteomes.

Authors:  Michael L Paull; Tim Johnston; Kelly N Ibsen; Joel D Bozekowski; Patrick S Daugherty
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

6.  Antibody characterization using immunosignatures.

Authors:  Phillip Stafford; Stephen Albert Johnston; Orhun H Kantarci; Ameneh Zare-Shahabadi; Arthur Warrington; Moses Rodriguez
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.